La Montagne chaired the World Health Organization Task Force on Strategic Planning for the Children's Vaccine Initiative, advised the Pan American Health Organization on programs for vaccine - research implementation, and served as a member of the board for the Global Alliance
for Tuberculosis Drug Development.
Not exact matches
Cycloserine, a
drug used to treat dangerous multidrug - resistant
tuberculosis, was just increased in price to $ 10,800
for 30 pills from $ 500 after its acquisition by Rodelis Therapeutics.
These include the infant with galactosemia, 53,54 the infant whose mother uses illegal
drugs, 55 the infant whose mother has untreated active
tuberculosis, and the infant in the United States whose mother has been infected with the human immunodeficiency virus.56, 57 In countries with populations at increased risk
for other infectious diseases and nutritional deficiencies resulting in infant death, the mortality risks associated with not breastfeeding may outweigh the possible risks of acquiring human immunodeficiency virus infection.58 Although most prescribed and over-the-counter medications are safe
for the breastfed infant, there are a few medications that mothers may need to take that may make it necessary to interrupt breastfeeding temporarily.
The Russian government has recently implemented more rigorous health requirements
for adopting parents — a history of psychiatric disorders,
drug and alcohol addictions,
tuberculosis, and infectious diseases,
for example, may disqualify potential parents.
Breastfeeding is also not recommended
for women who have a health issue such as HIV or
tuberculosis, those who use illegal
drugs, or women who have to take certain prescription medications that are not compatible with breastfeeding.
Breastfeeding is contraindicated in infants with classic galactosemia (galactose 1 - phosphate uridyltransferase deficiency) 103; mothers who have active untreated
tuberculosis disease or are human T - cell lymphotropic virus type I — or II — positive104, 105; mothers who are receiving diagnostic or therapeutic radioactive isotopes or have had exposure to radioactive materials (
for as long as there is radioactivity in the milk) 106 — 108; mothers who are receiving antimetabolites or chemotherapeutic agents or a small number of other medications until they clear the milk109, 110; mothers who are using
drugs of abuse («street
drugs»); and mothers who have herpes simplex lesions on a breast (infant may feed from other breast if clear of lesions).
So are
drugs for tuberculosis, leprosy, epilepsy or
for psychiatric illness.
«
For example, some cancers may not impact many patients and some antibacterial drugs, such as that for drug - resistant tuberculosis, may not be profitable, but it is almost a responsibility of biomedical researchers in academics to do something about it.&raq
For example, some cancers may not impact many patients and some antibacterial
drugs, such as that
for drug - resistant tuberculosis, may not be profitable, but it is almost a responsibility of biomedical researchers in academics to do something about it.&raq
for drug - resistant
tuberculosis, may not be profitable, but it is almost a responsibility of biomedical researchers in academics to do something about it.»
Using the second
drug with bedaquiline made
tuberculosis bacteria more vulnerable, pointing to a potential strategy
for dealing with persistent infections.
The
drug turns off some of the regulators
for the overactive
tuberculosis gene network that was fighting off the bedaquiline.
New research conducted at the Center
for Tuberculosis Research at the Johns Hopkins University School of Medicine shows that lower doses of the toxic
drug bedaquiline — given together with verapamil, a medication that's used to treat various heart conditions — can lead to the same antibacterial effects as higher toxic doses of bedaquiline.
The team analysed
drug sales data to show that the actual number of
tuberculosis cases in India may be vastly under - reported, primarily because many people opt
for treatment from private healthcare providers, who usually fail to report
tuberculosis cases to public health officials.
The standard treatment regimen
for drug - sensitive
tuberculosis comprises four different
drugs.
Current
drug therapies
for drug - sensitive
tuberculosis require six to eight months of treatment;
for drug - resistant
tuberculosis, treatment can take as long as two years.
Frieden said the halt has raised concerns from researchers working on
drug - resistant
tuberculosis, the Ebola outbreak in Africa, and preparations
for next season's influenza vaccine.
Nearly 40 % of all
drug - resistant
tuberculosis cases occur in Russia, India, the Philippines, and South Africa — accounting
for more than 230000 cases of
drug - resistant disease in 2015.
«The discovery of an alternative binding site and the AAPs represents a significant step towards the identification of a novel RNAP inhibitor that would behave like rifampin but be devoid of any pre-existing resistance,» said Nader Fotouhi, Chief Scientific Officer at the Global Alliance
for TB
Drug Development, a not - for - profit organization dedicated to finding faster - acting and affordable drug regimens to fight drug sensitive and resistant tuberculo
Drug Development, a not -
for - profit organization dedicated to finding faster - acting and affordable
drug regimens to fight drug sensitive and resistant tuberculo
drug regimens to fight
drug sensitive and resistant tuberculo
drug sensitive and resistant
tuberculosis.
«
Tuberculosis (TB) remains a major global health problem and identifying new
drug targets and candidate
drugs is a major priority,» said David S. Perlin, Executive Director and Professor at the Public Health Research Institute and Rutgers Regional Biocontainment Laboratory at the International Center
for Public Health at Rutgers New Jersey Medical School in Newark.
There are two forms of
drug - resistant
tuberculosis important to public health — multidrug - resistant
tuberculosis is resistant to more than one of the first - line
drugs for the disease, whereas extensively
drug - resistant
tuberculosis is additionally resistant to fluoroquinolones and at least one of the second - line injectable
tuberculosis drugs.
The study authors propose that increased spread from person to person will be responsible
for the growing number of
drug - resistant
tuberculosis cases.
Backup plan Sven Hoffner, a clinical mycobacteriologist at the Swedish Institute
for Communicable Disease Control in Solna, says that
drug - resistant
tuberculosis is «a manmade problem», often because
drugs are not available or of poor quality.
The study followed 1,055 household contacts of 213 individuals with MDRTB infection (defined by resistance to the
drugs rifampicin and isoniazid), and 2,362 household contacts of 487 individuals with
drug - susceptible
tuberculosis for up to three years.
Previous laboratory findings as well as estimates of fitness based on genetic clustering of strains in the population suggested a lower relative fitness
for MDRTB compared to
drug - susceptible
tuberculosis, but few studies have directly measured the incidence of second cases of
tuberculosis among contacts of both MDRTB and
drug - susceptible
tuberculosis.
«We hope to refine these multivariable descriptions so that we can anticipate the cyclic changes to
drug susceptibility in mycobacteria, and eventually use them to shorten the long and difficult treatment course
for tuberculosis.»
Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short - course treatment regimen
for drug - resistant
tuberculosis could substantially reduce the global incidence and spread of the disease.
And unlike
for most other
drug - resistant pathogens, we have evidence that, with a comprehensive response,
drug - resistant
tuberculosis epidemics can be rapidly reversed.
«Promising class of antibiotics discovered
for treatment of
drug - resistant
tuberculosis.»
6 - dependent protein, potentially opening avenues
for new antibiotics and
drugs to battle diseases such as
drug - resistant
tuberculosis, malaria and diabetes.
The so - called «international» edition of HIV / AIDS Medicine features up - to - date clinical information on HIV / AIDS, such as the best treatment options
for patients with
drug - resistant
tuberculosis — a condition often found among HIV - positive individuals — but also includes specialized chapters on managing and treating HIV and AIDS in resource - poor settings.
WHO guidelines
for the programmatic management of
drug - resistant
tuberculosis: 2011 update.
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests
for more rapidly diagnosing
drug - resistant forms of
tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health.
Aaron's work involves the management of projects and assays involved in
drug discovery
for tuberculosis.
The project that is farthest along involves the discovery of small molecules
for use in combination with
drugs of last resort
for extensively
drug - resistant
tuberculosis infections.
Higher frequency of genetic variants conferring increased risk
for ADRs
for commonly used
drugs treating cancer, AIDS and
tuberculosis in persons of African descent.
As with other biologics, patients should undergo testing
for tuberculosis before starting Stelara, and while taking the
drug they should be tested
for TB once a year.
«It's the case in measles, it's the case
for drug - resistant
tuberculosis, it's the case
for MERS and SARS and Ebola.
Garlic has even been suggested as a treatment
for drug - resistant
tuberculosis.
Mycobacterium
tuberculosis (Mtb) DprE1, an essential isomerase
for the biosynthesis of the mycobacterial cell wall, is a validated target
for tuberculosis (TB)
drug development.
Stacy Byers, PhD, Washington State University «Reducing the Risk of Transmission of Pathogenic Bacteria to Bighorn Sheep» Mary Klinck, DVM, University of Montreal «Creating Validated Pain Scales
for Feline Osteoarthritis Pain Identification and Quantification» Alex Davies, PhD University of California — Davis «Understanding Mechanisms that Contribute to Early Changes in Cancer Stem Cells» Kristen Messenger, DVM, North Carolina State University «Analgesic
Drug Therapy in Animals» Tiffany Wolf, DVM, University of Minnesota «Identification of Factors Contributing to Mycobacterium
Tuberculosis Transfer between Humans and Great Apes»
The solutions examined were: fighting
tuberculosis through
drugs and improved case identification; getting cheap
drugs that treat acute heart disease to developing countries; combining a malaria prevention package (mosquito nets, DDT spray, etc.) with subsidies on new treatments; expanding immunization and micronutrient coverage
for children in developing nations; tobacco taxes in developing nations; and a multiple ‐ intervention approach to preventing and treating H.I.V. / AIDS; making investments in hospitals.